These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 9200475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.
    Grehan S, Herbert J, Whitehead AS.
    Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interleukin-1 and the acute-phase response: induction of mouse liver serum amyloid A mRNA by murine recombinant interleukin-1.
    Weinstein JA, Taylor JM.
    J Trauma; 1987 Nov; 27(11):1227-32. PubMed ID: 3119866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
    Tam FW, Smith J, Cashman SJ, Wang Y, Thompson EM, Rees AJ.
    Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C, Garcia-Trevijano ER, Ludwiczek O, Talabot D, Kaser A, Mato JM, Fritsche G, Weiss G, Gabay C, Avila MA, Tilg H.
    Eur Cytokine Netw; 2004 Jul; 15(4):303-11. PubMed ID: 15627638
    [Abstract] [Full Text] [Related]

  • 16. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E, Muga SJ, Locniskar MF, Fischer SM.
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
    Conti P, Panara MR, Fridas S, Barbacane RC, Grilli A, Placido FC, Reale M, Fiore S.
    Cell Immunol; 1993 Apr 01; 147(2):446-57. PubMed ID: 8384086
    [Abstract] [Full Text] [Related]

  • 18. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
    Carl VS, Gautam JK, Comeau LD, Smith MF.
    J Leukoc Biol; 2004 Sep 01; 76(3):735-42. PubMed ID: 15218058
    [Abstract] [Full Text] [Related]

  • 19. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
    Ricci S, Macchia G, Ruggiero P, Maggi T, Bossù P, Xu L, Medaglini D, Tagliabue A, Hammarström L, Pozzi G, Boraschi D.
    BMC Biotechnol; 2003 Sep 17; 3():15. PubMed ID: 13129437
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.